Managing anxiety and depression during treatment.
Here, we review the prevalence and treatment of anxiety and depression among patients with breast cancer. Cancer-related symptoms include similarities to responses to traumatic stress. Well-developed screening devices for identifying and tracking psychiatric comorbidity are discussed. Basic principles of psychopharmacology, and individual and group psychotherapy are presented. Finally, effects of effective treatment of anxiety and depression on quality of life and overall survival are reviewed.
Department of Psychiatry, Stanford School of Medicine, Stanford, California.
David
D
Spiegel
Michelle B
MB
Riba
D001007:Anxiety / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D001943:Breast Neoplasms / Q000523:psychology* / Q000628:therapy*; D015897:Comorbidity; D003863:Depression / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D005260:Female; D006801:Humans; D008403:Mass Screening; D015995:Prevalence; D011788:Quality of Life; D012893:Sleep Wake Disorders / Q000209:etiology; D016019:Survival Analysis; D016896:Treatment Outcome
anxiety; breast cancer; depression; outcome; psychopharmacology; psychotherapy; survival